Comparison of different assays to assess human papillomavirus (HPV) type 16- and 18-specific antibodies after HPV infection and vaccination

Clin Vaccine Immunol. 2013 Aug;20(8):1329-32. doi: 10.1128/CVI.00153-13. Epub 2013 Jun 5.

Abstract

We compared the measurement of human papillomavirus (HPV)-specific serum antibody levels with the virus-like-particle multiplex immunoassay (VLP-MIA), competitive Luminex immunoassay (cLIA), and glutathione S-transferase (GST) L1-based MIA. Using a large panel of serum samples, these assays showed mutually good correlations for both naturally induced and vaccine-derived HPV-specific antibody levels. However, an adaptation of the GST L1-based MIA resulted in an improved correlation with both cLIA and VLP-MIA.

Publication types

  • Comparative Study
  • Evaluation Study

MeSH terms

  • Antibodies, Viral / blood*
  • Antigens, Viral
  • Clinical Laboratory Techniques / methods*
  • Human papillomavirus 16 / immunology*
  • Human papillomavirus 18 / immunology*
  • Humans
  • Immunoassay / methods
  • Papillomavirus Infections / immunology*
  • Papillomavirus Vaccines / administration & dosage
  • Papillomavirus Vaccines / immunology*
  • Virosomes

Substances

  • Antibodies, Viral
  • Antigens, Viral
  • Papillomavirus Vaccines
  • Virosomes